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Abstract	 	
Aeromonas	salmonicida	is	a	Gram-negative	bacterium	that	can	infect	a	wide	host	range	of	fish	populations,	including	salmonids	and	non-salmonids	as	well	as	freshwater	and	marine	life.	A.	salmonicida	causes	the	disease	furunculosis,	which	can	cause	lethargy,	intestinal	inflammation,	ulcers,	hemorrhaging,	and	death.	The	infection	is	spread	through	fish-to-fish	contact,	and	the	presence	of	infection	can	have	devastating	effects	on	cultivated	fish	populations.	The	purpose	of	this	study	was	to	explore	the	ability	of	A.	salmonicida	to	incorporate	polyunsaturated	fatty	acids	(PUFAs)	into	its	lipid	profile	and	test	the	phenotypic	effects	thereof.	A.	salmonicida	cultures	were	grown	in	minimal	media	in	the	presence	or	absence	of	one	of	seven	PUFAs	Lipids	were	extracted	from	these	cultures	and	analyzed	for	lipid	modification	by	thin-layer	chromatography	and	ultra	performance	liquid	chromatography	and	tandem	mass	spectrometry,	showing	A.	salmonicida	capable	of	incorporating	all	seven	of	the	PUFAs	studied.	Phenotypic	effects	were	determined	through	the	use	of	assays	that	tested	for	biofilm	formation,	membrane	permeability,	and	antimicrobial	peptide	susceptibility.	It	was	found	that	the	PUFAs	18:2	and	22:6	caused	significant	(P	<	0.01)	decrease	in	biofilm	formation.	The	PUFAs	18:3γ,	20:4,	and	22:6	showed	significant	(P	<	0.001)	increases	in	membrane	permeability	as	tested	by	the	uptake	of	the	hydrophobic	compound	crystal	violet.	Additionally,	the	PUFAs	18:3γ,	20:5,	and	22:6	showed	significant	(P	<	0.001)	protection	against	the	antimicrobial	peptide	polymyxin	B.	The	prevalence	of	22:6	in	significant	phenotypic	effects	could	indicate	a	connection	between	the	ability	of	A.	salmonicida	to	utilize	the	long-chain	PUFA	and	its	role	as	a	fish	pathogen.
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Chapter	1:	Introduction	
1.1	Gram-Negative	Membranes	Gram-negative	bacteria	are	distinguished	from	their	Gram-positive	counterparts	by	the	fact	that	they	do	not	retain	crystal	violet	(CV)	dye	following	a	staining	technique	developed	by	Hans	Christian	Gram.	Gram-positive	bacteria	retain	CV,	appearing	purple	after	staining,	due	to	a	thick	layer	of	peptidoglycan	found	on	the	outside	of	the	membrane,	which	is	a	single	lipid	bilayer.1	Peptidoglycan	can	also	be	found	in	Gram-negative	bacteria—in	a	much	smaller	quantity	that	does	not	retain	CV	as	well—as	a	thin	layer	in	the	periplasmic	space	between	two	membranes	as	shown	in	Figure	1.1.	
	
Figure	1.1	Structural	model	of	a	Gram-negative	cell	envelope2	The	presence	of	two	membranes	makes	Gram-negative	bacteria	particularly	good	subjects	for	this	project’s	focus	on	membrane	remodeling.	The	two	membranes	are	lipid	
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bilayers,	denoted	as	the	inner	membrane,	which	has	an	interface	with	the	cytosol,	and	the	outer	membrane,	which	has	an	interface	with	extracellular	fluids.	Lipids	are	a	broad	classification	of	largely	nonpolar	bioorganic	molecules.	They	encompass	a	diverse	range	of	functions,	including	energy	storage,	signaling,	and	serving	as	the	structural	matrix	of	membranes.3	The	lipids	that	comprise	biological	membranes	consist	of	polar	head	groups	and	nonpolar	tail	groups.	This	amphiphilic	property	causes	a	hydrophobic	effect	that	drives	the	formation	of	bilayers,	as	the	nonpolar	tail	groups	favorably	group	together,	with	the	polar	head	groups	aligned	together	against	aqueous	interfaces,	such	as	the	periplasm,	cytosol,	and	extracellular	fluids.3	The	specific	lipids	that	comprise	the	membranes	of	Gram-negative	bacteria	are	phospholipids	(PLs)	and	lipopolysaccharides	(LPSs).	The	entirety	of	the	inner	membrane	is	comprised	of	phospholipids,	and	the	inner	leaflet	of	the	outer	membrane	(the	lipid	layer	that	interfaces	the	periplasm)	is	comprised	of	phospholipids,	while	the	outer	leaflet	of	the	outer	membrane	(the	lipid	layer	that	interfaces	extracellular	fluids)	is	comprised	of	LPSs.4	LPSs	are	largely	believed	to	contribute	to	many	Gram-negative	bacteria’s	pathogenic	nature.5	However,	the	focus	on	this	project	was	the	modification	of	PLs,	as	they	are	more	abundant	in	the	membrane.	
1.2	Phospholipids	and	Fatty	Acids		 Phospholipids	are	a	specific	subcategory	of	lipids,	characterized	as	such	by	the	presence	of	a	phosphate	group	in	the	polar	head	group.	Glycerophospholipids	are	specifically	of	interest,	due	to	their	natural	prevalence	in	all	biological	membranes.	Glycerophospholipids	consist	of	a	glycerol	backbone,	with	a	phosphate	group	at	the	sn-3	position	and	fatty	acyl	chains	at	the	sn-1	and	sn-2	positions,	as	shown	in	Figure	1.2.	The	
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phosphate	group	is	also	attached	to	a	more	polar	head	group,	which	is	the	first	means	of	identifying	a	glycerophospholipid.	The	most	common	head	groups	of	Gram-negative	species	are	ethanolamine,	denoted	as	phosphatidylethanolamine	(PE),	and	glycerol,	denoted	phosphatidylglycerol	(PG).6,	7	Figure	1.2	shows	an	example	of	a	PE	and	Figure	1.3	shows	an	example	of	a	PG.
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Figure	1.2.	Phosphatidylethanolamine	16:0/18:2.	The	sn-1,	sn-2,	and	sn-3	carbons	of	the	
glycerol	backbone	are	labeled.	
	
Figure	1.3.	Phosphatidylglycerol	16:0/18:2.	The	sn-1,	sn-2,	and	sn-3	carbons	of	the	glycerol	
backbone	are	labeled.	
sn1	
sn2	
sn3	
sn1	
sn2	
sn3	
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The	PL	is	subsequently	identified	according	to	the	characterization	of	the	sn-1	and	sn-2	chains,	which	are	esterified	fatty	acids	(FAs).	FAs	are	carboxylic	acids	with	long	hydrocarbon	side	chains.	These	FAs	are	characterized	by	length,	or	number	of	carbons,	and	degree	of	unsaturation,	or	number	of	double	bonds.	A	FA	can	be	either	saturated,	monounsaturated,	or	polyunsaturated,	meaning	it	contains	no	double	bonds,	a	single	double	bond,	or	more	than	one	double	bond,	respectively.	For	example,	a	polyunsaturated	fatty	acid	(PUFA)	with	twenty	carbons	and	three	double	bonds	would	be	denoted	as	20:3.	Additional	classification	includes	Δ-notation,	which	is	used	to	specify	the	location	of	any	double	bonds.	An	example	of	a	specific	20:3	FA	is	dihomo-γ-linolenic	acid,	which	can	also	be	specified	as	20:3	(Δ8,	11,	14),	showing	that	the	three	double	bonds	occur	between	C8	and	C9,	C11	and	C12,	and	C14	and	C15,	counting	from	the	carbonyl	carbon.	An	alternative	method	of	identifying	the	location	of	the	double	bonds	in	a	PUFA	is	by	specifying	whether	it	is	a	ω-3	or	a	ω-6	FA,	which	denotes	the	location	of	the	last	double	bond	in	the	chain,	counting	from	the	terminal	methyl	group.	The	classification	of	ω-3	or	ω-6,	combined	with	the	fact	that	the	double	bonds	in	most	PUFAs	tend	to	be	three	carbons	apart,	can	also	be	used	to	know	the	exact	locations	of	double	bonds.	The	PUFAs	used	in	this	study	were	linoleic	acid	(18:2),	α-linolenic	acid	(18:3α),	γ-linolenic	acid	(18:3γ),	dihomo-γ-linolenic	acid	(20:3),	arachidonic	acid	(20:4),	eicosapentaenoic	acid	(20:5),	and	docosahexaenoic	acid	(22:6).	The	structures	of	these	PUFAs	are	shown	in	Figures	1.4	through	1.10.	The	length	and	degree	of	unsaturation	of	a	fatty	acid	affect	many	of	the	molecule's	physical	properties,	such	as	polarity	and	melting	point.3	
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Figure	1.4	Linoleic	acid	(18:2)	
	
Figure	1.5	α-Linolenic	acid	(18:3α)	
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Figure	1.6	γ-Linolenic	acid	(18:3γ)	
	
	
	
	
	
	
Figure	1.7	Dihomo-γ-linolenic	acid	(20:3)	
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Figure	1.8	Arachidonic	acid	(20:4)	
	
Figure	1.9	Eicosapentaenoic	acid	(20:5)	
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Figure	1.10	Docosahexaenoic	acid	(22:6)			 	
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1.3	Previous	Research	Most	naturally	occurring	fatty	acids	in	Gram-negative	bacteria	are	either	fully	saturated	or	monounsaturated,	with	few,	if	any,	PUFAs	occurring	natively.8	This	also	extends	to	the	acyl	chain	identities	of	native	phospholipids.	Because	the	additional	double	bonds	present	in	PUFAs	affect	properties	such	as	melting	point	and	polarity,	the	incorporation	of	PUFAs	into	the	phospholipid	profile	of	Gram-negative	bacteria	would	be	expected	to	cause	alterations	to	biological	properties	of	the	membrane	(e.g.	membrane	fluidity	and	membrane	lipid	homeostasis)	and	therefore	affect	functions	carried	out	by	the	membrane.	Previous	research	has	shown	that	membrane	modification	via	PUFA	incorporation	in	certain	Gram-negative	species	can	result	in	alteration	to	biological	functions	such	as	motility,	permeability,	biofilm	formation,	and	susceptibility	to	antimicrobial	peptides.9-12	The	mechanism	by	which	Gram-negative	bacteria	utilize	exogenous	fatty	acids	in	lipid	modification	has	been	studied	using	the	model	organism	Escherichia	coli.13,	14	The	process	begins	with	the	FadL	gene,	which	encodes	the	outer	membrane	protein	(FadL)	that	acts	as	a	transporter	of	long-chain	fatty	acids.13	The	fatty	acid	is	then	converted	to	an	acyl-CoA	thioester	by	the	acyl-coenzyme	A	(CoA)	synthetase,	FadD.9	At	this	point,	the	acyl-CoA	can	either	be	β-oxidized,	or	it	can	be	used	for	phospholipid	synthesis	via	the	acyltransferases	PlsB	and	PlsC.14,	15	The	presence	of	FadL,	FadD,	PlsB,	and	PlsC	homologs	in	other	Gram-negative	species	can	indicate	ability	to	utilize	exogenous	PUFAs	in	lipid	modification	rather	than	β-oxidation.9	Previous	work	has	also	shown	the	efficacy	of	ultra	performance	liquid	chromatography	with	tandem	mass	spectrometry	(UPLC-MS)	in	detection	and	identification	of	lipids.7,	16-21	Reversed-phase	liquid	chromatography	is	a	powerful	means	of	separating	mixtures	of	
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lipids,	which	are	all	hydrophobic	molecules.	Following	this	separation	of	lipids	of	interest,	mass	spectrometry	is	utilized	to	detect	mass:charge	(m/z)	ratios	of	the	molecules.	Specifically,	electrospray	ionization	(ESI)	is	widely	used	in	the	study	of	phospholipids7,	16-18,	
21,	as	many	classes	of	phospholipids	can	acquire	either	a	positive	or	negative	charge	in	the	mass	spectrometer	source.	When	analyzed	using	negative-mode	ionization	(ESI(-)),		phospholipids	molecular	ions	appear	as	negative	ions	after	single	deprotonation	of	the	phosphate	group,	notated	as	[M-H]-.	ESI(-)	can	also	cause	distinctive	fragmentation	of	phospholipids,	such	as	the	loss	of	the	acyl	chains	from	the	sn-1	and	sn-2	positions	as	fully	intact	carboxylate	ions.16,	17,	21	The	cleaved	acyl	chains	are	negatively	charged	and	can	therefore	be	detected	in	ESI	(-)	mode,	allowing	for	a	richer	analysis	of	the	lipids	of	interest.	
1.4	Aeromonas	salmonicida		 Aeromonas	salmonicida	is	a	Gram-negative	bacteria	that	was	discovered	by	Emmerich	and	Weibel	in	1894	at	a	Bavarian	brown	trout	hatchery.22	It	is	a	widespread	fish	pathogen	that	was	initially	believed	to	solely	infect	the	salmonids,	such	as	Atlantic	salmon,	brown	trout,	and	sea	trout,	but	the	host	range	has	since	been	expanded	to	include	freshwater	non-salmonids,	such	as	American	eel,	catfish,	northern	pike,	and	smallmouth	bass,	as	well	as	marine	non-salmonids,	such	as	Atlantic	cod	and	sea	bream.22,	23	Infection	by	
A.	salmonicida	is	referred	to	as	furunculosis,	and	symptoms	can	vary	depending	on	the	classification	of	the	infection.	Paracute	furunculosis	occurs	in	young	fish	and	usually	lacks	any	telltale	markers	because	it	results	in	rapid	death.	Similarly,	acute	furunclosis	is	typically	fatal	within	2	to	3	days,	but	infected	fish	can	display	skin	lessions.	Chronic	furunculosis	occurs	in	older	fish	and	has	a	lower	rate	of	mortality	than	paracute	and	acute	
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infections.23	Symptoms	of	chronic	furunculosis	include	lethargy,	intestinal	inflammation,	hemorrhages	in	muscle	and	liver,	as	well	as	the	furuncles	for	which	the	disease	is	named.			 A.	salmonicida	is	a	non-motile	bacterium	with	recorded	temperatures	of	18°C	to	26°C	being	optimal	for	growth.22,	24	It	was	widely	accepted	that	A.	salmonicida	could	not	grow	at	37°C	and	therefore	did	not	pose	a	risk	to	humans.22	However,	a	recent	case	study	has	reported	the	first	known	case	of	isolation	of	A.	salmonicida	from	a	human	blood	sample.25	While	this	was	an	isolated	incident,	and	A.	salmonicida	does	not	pose	significant	risk	to	humans	directly,	infections	can	have	devastating	effects	on	fish	populations	cultivated	as	food	sources.23	The	disease	spreads	from	contact	with	infected	fish.	While	the	pathogenesis	of	A.	salmonicida	is	not	especially	well	understood,	it	is	largely	contributed	to	two	factors:	cell-surface	structures	and	extracellular	products	excreted	by	the	cell.22		 Current	treatment	of	furunculosis	infections	includes	vaccination,	selective	breeding,	and	antibiotic	use.22,	23	However,	each	of	these	methods	of	disease	control	is	limited.	For	example,	vaccination	has	been	used	successfully	in	salmonid	populations,	but	has	not	been	explored	in	non-salmonids.26	Therefore,	there	is	still	need	for	exploration	of	novel	treatment	methods.	This	project	sought	to	determine	the	ability	of	A.	salmonicida	to	incorporate	exogenous	PUFAs	into	its	lipid	profile	and	biological	effects	thereof,	including	susceptibility	to	an	antimicrobial	peptide,	which	could	potentially	affect	future	therapeutic	efforts.	
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Chapter	2:	Materials	and	Methods	
2.1	Growth	procedure	for	UPLC-MS	and	TLC	analysis		
Aeromonas	salmonicida	subsp.	salmonicida	(ATCC®	33658™)	was	obtained	from	American	Type	Culture	Collection	and	was	used	in	this	and	all	subsequent	experiments.	Overnight	cultures	of	A.	salmonicida	were	prepared	by	aseptically	transferring	colonies	of	A.	
salmonicida	from	a	Luria	agar	plate	to	sterile	glass	tubes	containing	4-mL	Luria	broth	(LB).	These	cultures	grew	at	room	temperature	with	shaking	on	a	New	Brunswick	Scientific	Innova	2100	platform	shaker	at	200	rotations	per	minute	(rpm)	and	were	transferred	to	15-mL	polypropylene	conicals	and	centrifuged	in	a	Corning	LSE	compact	centrifuge	at	4250	rpm	for	10	minutes	the	following	morning.	The	supernatant	was	discarded,	and	the	pelleted	bacteria	were	washed	with	1-mL	CM9	minimal	media	(0.4%	glucose,	0.2%	Casamino	Acids)	and	centrifuged	again	at	4250	rpm	for	5	minutes.	Again,	the	supernatant	was	discarded	and	the	washed	pellet	was	gently	resuspended	by	pipette	in	1-mL	CM9.	The	optical	density	(OD)	of	the	resuspended	cells	was	measured	with	a	Thermo	Scientific	Genesys	10S	UV-Vis	Spectrophotometer	at	600	nm	(OD600).	This	culture	was	then	used	to	inoculate	eight	20-mL	CM9	cultures	to	a	starting	OD600	of	0.1	in	50-mL	polypropylene	conicals.	Seven	of	those	cultures	were	supplemented	with	300	μM	of	one	of	the	seven	PUFAs	studied		(18:2,	18:3α,	18:3γ,	20:3,	20:4,	20:5,	or	22:6).	All	PUFAs	were	obtained	from	Cayman	Chemical	Company.	These	cultures	were	grown	at	23°C	in	a	Thermo	Scientific	MaxQ	4000	incubator	with	shaking	at	200	rpm	to	an	OD600	of	approximately	0.9.	To	cease	growth,	the	20-mL	cultures	were	pelleted	via	centrifugation	at	4250	rpm	for	10	minutes,	after	which	the	supernatant	was	discarded.	The	pellet	was	then	washed	with	1-mL	CM9	
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and	centrifuged	again	at	4250	rpm	for	5	minutes	and	the	supernatant	was	discarded.	Pelleted	cultures	were	stored	at	-20°C	until	lipid	extractions	were	performed.	Cultures	grown	for	analysis	by	thin-layer	chromatography	(TLC)	were	grown	identically	to	the	above	procedure,	except	14-mL	cultures	were	prepared	as	opposed	to	20-mL	cultures.	
2.2	Bligh	and	Dyer	Lipid	Extractions	Lipid	extractions	for	both	TLC	and	UPLC-MS	analysis	were	performed	according	to	the	procedure	outlined	by	Bligh	and	Dyer.27	Stored	bacterial	pellets	were	resuspended	in	5-mL	single-phase	Bligh/Dyer	mixture	(1:2:0.8	chloroform:methanol:water)	and	immediately	transferred	via	glass	Pasteur	pipette	to	clean	10-mL	glass	tubes.	These	tubes	were	capped	and	vortexed,	and	the	mixture	sat	for	20	minutes,	with	additional	vortexing	after	10	minutes.	This	process	lysed	the	cells,	allowing	the	lipids	to	be	freed	into	solution.	After	lysing,	the	tubes	were	centrifuged	for	10	minutes	at	4000	rpm	such	that	the	supernatant	contained	the	lipids	of	interest	and	cellular	components	that	were	not	of	interest	were	pelleted.	The	supernatant	was	removed	and	placed	into	clean	10-mL	glass	tubes	to	which	1.3-mL	chloroform	and	1.3-mL	water	were	added	to	create	a	two-phase	Bligh/Dyer	mixture	consisting	of	an	aqueous	upper	phase	and	an	organic	lower	phase.	This	mixture	was	homogenized	by	vortexing	and	then	centrifuged	at	4000	rpm	for	10	minutes.	The	lower	phase	containing	the	lipids	of	interest	partitioned	into	the	chloroform	was	gently	removed	with	a	glass	Pasteur	pipette	and	placed	in	a	clean	10-mL	glass	tube.	An	additional	2.6-mL	aliquot	of	chloroform	was	added	to	the	original	tubes	(now	containing	only	the	upper	aqueous	phase	from	the	previous	step)	in	order	to	reestablish	a	two-phase	Bligh/Dyer	mixture.	This	was	then	vortexed	and	centrifuged	at	4000	rpm	for	10	minutes,	and	the	lower	phase	was	extracted	as	before	and	pooled	with	the	previous	extraction.	To	
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purify	the	extractions,	the	two-phase	Bligh/Dyer	mixture	was	reestablished	with	the	pooled	lower	phases	by	adding	5.2-mL	methanol	and	4.68-mL	water	to	them.	This	was	then	vortexed	and	centrifuged	at	4000	rpm	for	five	minutes.	The	lower	phase	was	again	extracted	gently	by	glass	Pasteur	pipette	and	placed	into	clean	5-mL	glass	tubes.	These	constituted	the	final	lipid	extracts,	which	were	dried	down	to	remove	all	solvent	under	a	gentle	stream	of	nitrogen	gas	on	an	N-EVAP	111	Nitrogen	Evaporator.	Dried	lipid	extracts	were	stored	at	-20°C	until	weighing	and	transferring.	
2.3	Thin-Layer	Chromatography	Lipids	extracted	from	the	14-mL	cultures	were	spotted	onto	a	silica	gel	60	TLC	plate.	A	solvent	system	of	chloroform-methanol-acetic	acid	(65:25:10,	volumetrically)	was	used	to	separate	lipids	in	a	closed	chamber.	The	tank	system	containing	the	solvent	was	equilibrated	for	two	hours	prior	to	placing	the	TLC	plate	inside.	Once	the	solvent	reached	the	top	of	the	plate,	it	was	removed	from	the	chamber	and	allowed	to	dry.	A	solution	of	10%	sulfuric	acid	in	100%	ethanol	was	used	to	coat	the	plate,	and	it	was	subsequently	developed	on	a	hot	plate	at	150°C	just	until	lipids	appeared.	A	Canon	CanoScan	LiDE	210	was	used	to	scan	the	plate	immediately	after	developing.	
2.4	UPLC-MS	
2.4.1	Preparing	lipids	for	UPLC-MS	Empty	Waters	LCMS	Certified	Amber	Screw-Top	vials	and	lids	were	weighed	in	triplicate	on	a	Mettler	Toledo	XS205	DualRange	analytical	balance.	Pasteur	pipettes	were	used	to	resuspend	lipid	extracts	in	2:1	chloroform:	methanol	and	to	transfer	lipids	in	solution	from	test	tubes	to	amber	vials.	This	transfer	process	was	repeated	three	times	to	ensure	all	lipids	were	transferred.	A	total	of	approximately	1-mL	of	the	2:1	solution	was	used	for	each	
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transfer.	Lipid	solutions	in	amber	vials	were	dried	to	constant	mass	under	a	stream	of	N2	gas	to	remove	all	solvent.	Vials	now	containing	dried	lipids	were	weighed	in	triplicate,	and	masses	of	dried	lipids	were	determined	by	subtracting	average	mass	of	empty	amber	vials	from	the	average	mass	of	amber	vials	containing	dried	lipids.	A	table	of	the	triplicate	weighings	and	final	mass	values	is	provided	in	the	supplemental	material.	Parent	solutions	of	dried	lipid	extracts	were	made	by	adding	1-mL	4:1	chloroform:	methanol	and	vortexing	to	ensure	all	lipids	were	in	solution.	Working	solutions	of	400-ppm	total	lipid	extract	were	then	prepared	from	the	parent	solutions.	Appropriate	aliquots	of	parent	solutions	were	transferred	to	empty	Waters	LCMS	Certified	Max	Recovery	vials	and	allowed	to	dry	under	N2	gas	on	an	N-EVAP	111	Nitrogen	Evaporator.	The	dried	lipids	were	then	suspended	in	100-μL	MeOH	(B1)	with	vortexing.	To	this	solution,	100-μL	30:70	25-mM	ammonium	acetate:	MeOH	(A1)	was	added,	such	that	the	final	solution	was	a	suspension	of	extracted	lipids	in	200-μL	of	50:50	A1:B1.	
2.4.2	UPLC-MS	Full	Scan	Parameters	Ultra	performance	liquid	chromatography	and	tandem	mass	spectrometry	measurements	were	performed	on	a	Waters	ACQUITY-UPLC	System	interfaced	to	a	Quattro	Micro	API	triple	quadrupole	mass	spectrometer	with	electrospray	ionization	(ESI)	source.	Full	scans	of	the	400-ppm	lipid	extractions	were	performed	on	a	BEH	C-8	reversed	phase	column	with	gradient	elution.	The	solvents	used	as	the	mobile	phase	were	defined	as	A1	(30:70	25mM	ammonium	acetate:	MeOH)	and	B1	(MeOH).	All	solvents	used	were	Optima	grade	(Fisher	Scientific),	and	water	was	18.2-MΩ	cm	from	a	Direct	Q3	Milli-Q	system.	A	flow	rate	of	0.300-mL/min	was	used	and	5-μL	of	the	400-ppm	working	solution	was	injected	onto	the	column	for	analysis.	Gradient	elution	consisted	of	50:50	A1:B1	held	constant	for	2	
	 17	
minutes,	followed	by	a	constant	increase	in	the	amount	of	B1	present	until	the	mobile	phase	consisted	of	100%	B1	at	10	minutes.	Immediately	after	the	establishment	of	100%	B1,	B1	was	rapidly	decreased	back	to	initial	conditions	(50:50	A1:	B1)	by	10.3	minutes	and	held	constant	until	the	end	of	run	time	at	11	minutes.	Following	separation	via	LC,	the	analytes	entered	the	Quattro	Micro	API	triple	quadrupole	mass	spectrometer	where	they	were	ionized	via	ESI	in	negative	mode	with	a	capillary	voltage	of	1.5-kV.	Inert	nitrogen	gas	at	a	flow	rate	of	600-L/h	and	a	temperature	of	350°C	was	used	in	desolvation	of	the	sample.	After	ionization,	negatively	charged	molecules	passed	through	a	50-V	cone	into	the	quadrupole	mass	spectrometer,	where	scans	were	conducted	from	200	m/z	to	1500	m/z.	Scan	time	was	0.5	seconds	with	an	interscan	delay	of	0.01	seconds.	The	photomultiplier	tube	detector	was	operated	at	650	V.	All	chromatograms	and	mass	spectra	were	analyzed	with	MassLynx	V4.1	software.															2.4.3	SIR	Scans	In	addition	to	full	scans,	which	are	defined	above	as	the	constant	scanning	from	200	m/z	to	1500	m/z,	selected	ion	recording	(SIR)	scans	were	also	conducted	on	all	lipid	samples	of	A.	
salmonicida	grown	in	the	presence	of	a	PUFA.	All	UPLC	and	MS	parameters	remain	the	same	as	those	used	for	full	scans,	but	instead	of	scanning	across	a	range	of	m/z	values,	a	select	few	m/z	values	were	scanned.	Specifically,	the	m/z	values	corresponding	to	the	[M-H]-	values	of	the	most	likely	modified	PLs	were	scanned.	Table	2.1	shows	the	m/z	values	that	were	selected	for	scanning	for	each	different	PUFA.	This	scanning	method	allows	for	increased	sensitivity	by	decreasing	noise	that	can	be	found	in	full	scans.	The	selectivity	of	SIR	scans	can	also	be	a	downfall	in	analysis	of	modified	PLs,	as	discussed	further	in	results.		
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Table	2.1	m/z	values	corresponding	to	the	[M-H]-	values	of	common	possible	modified	lipids	where	x	
corresponds	to	the	identity	of	the	modifying	PUFA		 PG	16:0/x	 PG	16:1/x	 PG	18:0/x	 PG	18:1/x	 PG		x/x	 PE	16:0/x	 PE	16:1/x	 PE	18:0/x	 PE	18:1/x	 PE		x/x	18:2	 745.5	 743.5	 773.5	 771.5	 769.5	 714.5	 712.5	 742.5	 740.5	 738.5	18:3α	 743.5	 741.5	 771.5	 769.5	 765.5	 712.5	 710.5	 740.5	 738.5	 734.5	18:3γ	 743.5	 741.5	 771.5	 769.5	 765.5	 712.5	 710.5	 740.5	 738.5	 734.5	20:3	 771.5	 769.5	 799.5	 797.5	 821.5	 740.5	 738.5	 768.5	 766.5	 790.5	20:4	 769.5	 767.5	 797.5	 795.5	 817.5	 738.5	 736.5	 766.5	 764.5	 786.5	20:5	 767.5	 765.5	 795.5	 793.5	 813.5	 736.5	 734.5	 764.5	 762.5	 782.5	22:6	 793.5	 791.5	 821.5	 819.5	 865.5	 762.5	 760.5	 790.5	 788.5	 834.5	
	
														2.4.4	Fatty	acid	calibration	curves	The	fatty	acids	linoleic	acid	(18:2)	and	docosahexaenoic	acid	(22:6)	were	used	to	create	calibration	curves	by	plotting	chromatographic	peak	area	vs.	concentration.	Concentrations	of	0.5,	1,	2,	and	5	ppm	of	each	of	the	fatty	acids	were	made	in	50:50	A1:B1,	and	these	were	analyzed	by	the	UPLC-MS	parameters	described	above	with	the	exception	that	chromatography	on	the	same	gradient	was	only	run	for	four	minutes	and	m/z	values	were	scanned	from	100	to	400.	QuanLynx	software	was	used	to	determine	peak	area	of	chromatographic	peaks	and	develop	linear	regressions.		
2.5	Growth	Curves	Cultures	were	prepared	from	A.	salmonicida	cultures	grown	overnight	in	LB.	Prepared	cultures	were	grown	with	shaking	in	CM9	(0.4%	gluclose,	0.4%	Casamino	Acids)	at	a	starting	OD600	of	0.05	either	in	the	presence	or	absence	of	300-μM	of	each	of	the	PUFAs	(note:	slightly	higher	concentration	of	Casamino	Acids	was	supplemented	into	media	used	in	assays	as	opposed	to	that	used	in	growth	of	cultures	for	TLC	and	UPLC-MS	analysis).	One	
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set	of	cultures	was	grown	at	23°C	in	a	Thermo	Scientific	MaxQ	4000	incubator	with	shaking	and	another	set	of	cultures	was	grown	at	28°C	in	a	Thermo	Scientific	Precision	incubator	with	shaking.	OD600	readings	of	all	cultures	were	taken	with	a	Thermo	Scientific	Genesys	10S	UV-Vis	Spectrophotometer	every	hour	for	eleven	hours.	
2.6	Biofilm	Formation	Assay	Formation	of	biofilm	was	tested	by	a	procedure	designed	by	O’Toole.28	Inoculum	at	an	OD600	of	0.12	in	CM9	was	prepared	from	A.	salmonicida	cultures	grown	overnight	in	LB.	Additionally,	dilutions	of	the	individual	PUFAs	were	prepared	in	CM9.	170-μL	of	inoculum	was	pipetted	via	multichannel	pipette	into	the	wells	of	a	96-well	microtiter	plate.	30-μL	of	either	a	PUFA	dilution	or	CM9	with	no	PUFA	was	added,	such	that	the	biofilm	formation	of	
A.	salmonicida	in	the	presence	of	each	of	the	seven	PUFAs	and	no	PUFA	was	performed	in	octuplet.	The	final	starting	OD600	was	0.1,	and	the	PUFA	dilutions	were	designed	such	that	the	final	concentration	was	300μM.	The	microtiter	plate	was	statically	incubated	at	28°C	for	24	hours.	After	24	hours	of	incubation,	cultures	were	removed	from	the	microtiter	plate	by	shaking	them	out.	The	plate	was	gently	rinsed	by	submerging	in	deionized	water	and	shaking	again.	Excess	liquid	was	removed	by	tapping	on	paper	towels,	and	the	plate	was	allowed	to	dry	before	proceeding.	After	dry,	225-μL	of	a	0.1%	solution	of	crystal	violet	(CV)	was	added	via	multichannel	pipette	to	each	well.	This	was	allowed	to	sit	at	room	temperature	for	15	minutes.	CV	solution	was	removed	by	gentle	rinsing	with	deionized	water,	as	described	above.	The	plate	was	then	allowed	to	dry	completely.	Colorimetric	analysis	of	biofilm	was	performed	by	adding	225-μL	of	30%	acetic	acid	solution	to	each	well	via	multichannel	pipette	and	allowing	them	to	sit	for	15	minutes,	such	
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that	CV	would	go	into	solution.	Acetic	acid-CV	solutions	were	then	transferred	to	a	clean	microtiter	plate,	which	was	read	on	a	BioTek	Synergy	microplate	reader	at	590-nm.	Significance	(P	<	0.01)	was	established	with	Student’s	t-test	(two	tailed,	paired).	
2.7	Permeability	Assay	Permeability	was	tested	by	a	CV	uptake	assay.	Eight	6-mL	cultures	of	A.	salmonicida	either	in	the	presence	or	absence	of	300-μM	of	one	of	the	PUFAs	were	allowed	to	grow	with	shaking	at	28°C	in	CM9	minimal	media	to	OD600	of	approximately	0.9.	These	cells	were	captured	by	centrifuging	and	washed	with	Phosphate	Buffered	Saline	(PBS).	Cultures	were	normalized	to	OD600	of	0.80	in	5-mL	PBS	and	CV	was	added	to	the	cultures	such	that	each	contained	5-mg/mL	CV.	Readings	were	taken	by	capturing	1-mL	of	each	culture.	These	cultures	were	pelleted	via	centrifugation	for	one	minute	at	1000	rpm	in	a	Fisher	Scientific	AccuSpin	Micro	17	Centrifuge.	Following	centrifugation,	the	supernatant	was	collected	and	analyzed	by	a	Thermo	Scientific	Genesys	10S	UV-Vis	Spectrophotometer	at	590-nm.	Readings	were	taken	every	five	minutes	for	25	minutes,	and	cultures	were	allowed	to	gently	shake	at	room	temperature	between	readings.	Because	the	reading	of	the	supernatant	corresponded	to	the	amount	of	crystal	violet	not	taken	up	by	the	cells,	readings	were	converted	to	percentage	of	uptake	by	comparison	to	the	reading	of	a	sample	of	PBS	containing	5-mg/mL	CV	but	no	bacteria.	Significance	(P	<	0.001)	was	established	with	Student’s	t-test	(two	tailed,	paired).	
2.8	Polymyxin	B	Susceptibility	Assay	Cultures	were	grown	with	shaking	at	28°C	in	CM9	minimal	media	in	either	the	presence	or	absence	of	300-μM	of	one	of	the	PUFAs	to	OD600	of	approximately	0.9.	These	cultures	were	centrifuged,	washed	with	CM9,	and	used	to	create	cultures	of	OD600	0.12	that	were	
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supplemented	with	353-μM	of	one	of	the	PUFAs,	where	appropriate.	Additionally,	dilutions	of	Polymyxin	B	(PMB)	were	made	in	CM9,	with	concentrations	increasing	two-fold.	Microtiter	plates	were	prepared	by	use	of	multichannel	pipette	to	add	170-μL	of	the	prepared	cultures	to	wells	followed	by	30-μL	of	one	of	the	PMB	dilutions,	such	that	the	wells	contained	200-μL	altogether	at	a	starting	OD600	of	0.10	and	each	trial	was	run	in	triplicate.	Microtiter	plates	were	incubated	with	shaking	in	a	Thermo	Scientific	MaxQ	4000	incubator	at	28°C	in	for	24	hours.	Plates	were	lightly	covered	with	aluminum	foil	to	minimize	evaporation.	A	recent	study	has	found	that	significant	amounts	of	cationic	antimicrobial	peptides	(cAMPs)	can	adsorb	to	glassware	and	certain	plasticware,	causing	inadvertent	lowering	of	concentrations	in	studies	using	cAMPs.29	In	order	to	minimize	the	effect	of	this	adsorption,	PMB	dilutions	used	for	this	study	were	made	in	Protein	LoBind	tubes,	and	assays	were	run	in	polypropylene	microtiter	plates	to	ensure	accurate	concentrations	PMB.	In	addition,	polypropylene	plates	interfere	with	UV-Vis	readings	at	600	nm,	so	cultures	were	transferred	to	polystyrene	microtiter	plates	immediately	before	reading	on	a	BioTek	Synergy	microplate	reader	at	600	nm.	Significance	(P	<	0.01)	was	established	with	Student’s	t-test	(two	tailed,	paired).	
2.9	Bioinformatics	The	National	Center	of	Biotechnology	Information’s	Basic	Local	Alignment	Search	Tool	(BLAST)	was	utilized	to	search	for	homologs	of	E.	coli	MG1655	FadL,	FadD,	PlsB,	PlsC,	PlsX,	and	PlsY.	Only	homologs	with	a	maximum	score	greater	than	200	were	reported.	Homologs	are	reported	for	A.	salmonicida	subsp.	salmonicida	(A449).		
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Chapter	3:	Results	
3.1	Introduction	to	Results	The	purpose	of	this	project	was	to	determine	the	ability	of	A.	salmonicida	to	incorporate	exogenous	PUFAs	into	its	lipid	profile	and	any	biological	effects	thereof.	The	first	part	of	this	project	consisted	of	analysis	of	extracted	lipids	by	separation	via	UPLC	and	characterization	via	MS.	After	confirmation	of	incorporation	a	series	of	biological	assays	were	run	to	test	various	biological	functions,	including	growth,	biofilm	formation,	permeability,	and	antimicrobial	peptide	susceptibility.	
3.2	Thin-layer	chromatography	of	Aeromonas	salmonicida	samples	Figure	3.1	shows	the	TLC	conducted	on	extracted	lipids	of	A.	salmonicida	samples.	The	PG	and	PE	regions	are	labeled,	and	brackets	show	examples	of	the	presence	of	new	phospholipid	species	as	a	result	of	PUFA	incorporation.		
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Figure	3.1	Results	of	TLC	conducted	on	lipids	extracted	from	A.	salmonicia	samples	grown	in	
either	the	presence	or	absence	of	one	of	the	seven	PUFAs	studied.	Splitting	indicates	the	
presence	of	PL	species	not	present	in	the	control	sample,	likely	due	to	incorporation	of	PUFAs	
into	lipids.	
	
3.3	UPLC-MS	Analysis	of	Aeromonas	salmonicida	Samples	The	UPLC	separation	method	described	in	Section	2.4.2	allows	for	the	separation	of	free	fatty	acids	(FFAs)	from	glycerophospholipids,	and	even	allows	for	somewhat,	though	not	entirely,	distinct	regions	of	phosphatidylglycerols	(PGs)	and	phosphatidylethanolamines	(PEs).	This	separation	is	based	on	the	differences	in	polarity	between	the	species	of	interest.	Figure	3.2	shows	the	chromatogram	of	the	A.	salmonicida	control	sample,	with	the	FFA	and	PL	regions	labeled,	and	Figure	3.3	shows	a	closer	look	at	the	PL	region,	with	the	PG	and	PE	regions	labeled	to	demonstrate	this	chromatographic	separation.	It	should	be	noted	that	characterization	of	lipids	was	conducted	in	ESI	(-)	mode,	under	which	conditions	glycerophospholipids	appear	as	singly	deprotonated	[M-H]-	ions.	Because	
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the	lipids	are	singly	charged,	m/z	values	directly	relate	to	the	mass	of	the	lipids	less	one	hydrogen.	Several	methods	of	confirmation	were	used	in	the	characterization	of	lipids.	The	LIPID	Metabolites	and	Pathways	Strategy	(LIPID	MAPS)	database	was	utilized	to	confirm	potential	identities	of	parent	masses.	Additionally,	the	cone	voltage	utilized	in	the	mass	spectrometry	analysis	(50	V)	was	high	enough	to	result	in	mild	fragmentation	of	the	lipids,	referred	to	as	cone	fragments.	Often	the	most	abundant	cone	fragments	correspond	to	the	loss	of	fatty	acyl	chains	as	carboxylate	ions	from	the	sn-1	or	sn-2	position	of	the	glycerophospholipids.	These	cone	fragments	in	conjunction	with	the	parent	masses	and	chromatographic	separation	allow	for	the	positive	identification	of	phospholipids.	The	lipids	extracted	from	the	sample	of	A.	salmonicida	grown	in	the	absence	of	any	of	the	seven	PUFAs	of	interest	were	used	as	a	reference	to	compare	the	native	lipid	profile	of	A.	
salmonicida	to	the	modified	cultures,	confirming	that	the	PUFAs	of	interest	were	non-native.	Figure	3.3	also	shows	the	identities	of	the	major	chromatographic	peaks.	These	identities	were	determined	according	to	the	mass	spectra	of	the	peaks.	Figure	3.4	shows	the	average	mass	spectrum	of	the	peak	at	8.06	minutes	in	the	control	sample.	The	688.5	m/z	value	was	searched	in	the	LIPID	MAPS	database,	showing	that	the	value	corresponds	to	the	[M-H]-	m/z	value	of	PE	16:0/16:1.	Cone	fragments	further	confirmed	the	identity	of	the	lipid,	as	the	253.2	m/z	value	corresponds	to	a	16:1	acyl	chain	and	the	255.2	m/z	value	corresponds	to	a	16:0	acyl	chain.	A	similar	process	was	followed	in	determining	the	identities	of	the	other	peaks	labeled	in	Figure	3.3,	but	the	mass	spectra	have	been	omitted	for	the	sake	of	brevity.			
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Figure	3.2.	Chromatogram	of	A.	Salmonicida	control	sample,	distinguishing	between	the	free	fatty	acid	(FFA)	and	phospholipid	
(PL)	regions.
FFA Region
PL Region
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Figure	3.3.	Phospholipid	region	of	A.	Salmonicida	control	sample.	Separation	of	PGs	and	PEs	is	indicated	by	region,	and	major	
peaks	are	identified	according	to	the	corresponding	mass	spectra	data
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Figure	3.4.	The	average	mass	spectrum	of	the	peak	at	8.06	minutes	in	the	A.	salmonicida	control	sample	
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Figure	3.5	shows	the	chromatogram,	limited	to	the	phospholipid	region,	of	the	A.	
salmonicida	sample	grown	in	the	presence	of	linoleic	acid	(18:2).	Two	peaks	of	interest	are	labeled	A	and	B,	and	the	average	mass	spectra	of	these	peaks	are	shown	in	Figures	3.6	and	3.7,	respectively.	Analysis	of	the	average	mass	spectrum	of	peak	A	(Figure	3.5)	shows	it	to	be	PG	16:0/18:2.	The	745.5	m/z	value	corresponds	to	the	[M-H]-	of	PG	16:0/18:2,	which	was	confirmed	by	use	of	the	LIPID	MAPS	database.	Additionally,	the	cone	fragments	of	255.2	m/z	and	279.2	m/z	correspond	to	acyl	chains	16:0	and	18:2,	respectively.	Similarly,	the	identity	of	B	was	elucidated	from	the	714.5	m/z	value	corresponding	to	the	[M-H]-	of	PE	16:0/18:2,	which	was	confirmed	in	the	LIPID	MAPS	database.	Because	B	has	the	same	fatty	acyl	chains	as	A,	the	same	cone	fragments	of	255.2	m/z	and	279.2	m/z	can	be	found,	also	corresponding	to	16:0	and	18:2.	This	also	demonstrates	the	chromatographic	separation	of	PGs	and	PEs.	Despite	having	the	same	identifying	acyl	chains,	A	and	B	chromatograph	over	a	minute	apart,	as	shown	in	Figure	3.5,	with	the	more	polar	PG	species	eluting	earlier	than	the	analogous	PE	species	in	this	reversed-phase	chromatography.
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Figure	3.5.	Chromatogram	of	the	A.	Salmonicida	sample	grown	in	the	presence	of	linoleic	acid	(18:2);	only	the	phospholipid	region	
is	shown	
		
A
B
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Figure	3.7.	Average	mass	spectrum	of	the	peak	labeled	A	(6.92	minutes)	of	the	18:2	sample	 	
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	Figure	3.8	Average	mass	spectrum	of	the	peak	labeled	B	(8.32	minutes)	of	the	18:2	sample	 	
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The	phospholipid	region	of	the	chromatogram	of	the	A.	salmonicida	sample	grown	in	the	presence	of	α-linolenic	acid	(18:3α)	is	shown	in	Figure	3.8.	The	average	mass	spectrum	of	the	peak	at	7.00	minutes,	labeled	A,	is	shown	in	Figure	3.9.	The	684.5	m/z	value	is	the	[M-H]-	value	of	PE	14:0/18:3α,	which	was	confirmed	via	the	LIPID	MAPS	database.	Additionally,	cone	fragments	of	227.2	m/z	and	277.2	m/z	were	found,	which	correspond	to	14:0	and	18:3α,	respectively.	Additionally,	the	peak	at	424.2	m/z	indicates	the	neutral	loss	of	the	sn-2	acyl	chain	(18:3α)	as	a	ketene	(R2-CH=C=O).	Specifically,	the	424.2	m/z	corresponds	to	the	mass	remaining	after	this	loss,	which	can	be	indicated	as	[M-H-R2-CH=C=O]-.	This	is	another	cone	fragment,	caused	by	the	high	cone	voltage	used	in	the	MS	parameters.		
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Figure	3.8.	Chromatogram	of	A.	salmonicida	sample	grown	in	the	presence	of	α-linolenic	acid	(18:3α),	only	the	phospholipid	
region	is	shown	 	
A
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Figure	3.9.	Average	mass	spectrum	of	the	chromatographic	peak	labeled	A	(7.00	minutes)	in	Figure	3.7
A PE 14:0/18:3a
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Figure	3.10	shows	the	phospholipid	region	of	the	chromatogram	of	the	A.	salmonicida	sample	grown	in	the	presence	of	18:3γ.	The	average	mass	spectrum	of	the	chromatographic	peak	at	7.89	minutes,	labeled	A,	is	shown	in	Figure	3.11.	The	mass	spectrum	peaks	at	255.2	m/z	and	277.2	m/z	indicate	cone	fragments	of	16:0	and	18:3γ,	respectively.	Because	the	peak	at	712.5	m/z	is	an	even	value,	this	would	indicate	that	the	phospholipid	that	chromatographed	at	7.89	minutes	is	PE	16:0/18:3γ.	The	LIPID	MAPS	database	confirmed	at	712.4	m/z	corresponds	to	the	[M-H]-	of	PE	16:0/18:3γ.
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Figure	3.10.	Chromatogram	of	the	A.	salmonicida	sample	grown	in	the	presence	of	γ-linolenic	acid	(18:3γ),	only	the	phospholipid	
region	is	shown	 	
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Figure	3.11.	Average	mass	spectrum	of	the	peak	labeled	A	(7.89	minutes)	in	the	chromatogram	of	the	18:3γ	sample,	above
A	 PE	16:0/18:3γ	
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:3
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In	addition	to	fullscan	parameters,	selected	ion	recording	(SIR)	scans	were	also	utilized	to	identify	modified	phospholipids.	SIR	scans	only	scan	for	a	few	select	m/z	values	rather	than	the	entire	range	of	200-1400	m/z	that	is	scanned	under	fullscan	parameters.	This	allows	for	increased	sensitivity,	which	can	be	very	useful	in	the	detection	of	low	abundance	molecules.	Figure	3.12	shows	two	chromatograms	of	the	A.	salmonicida	sample	grown	in	the	presence	of	dihomo-γ-linolenic	acid	(20:3).	The	chromatogram	labeled	1	is	from	the	SIR	scan	of	the	sample,	which	selectively	scanned	for	masses	corresponding	to	possible	modified	PLs.	The	chromatogram	labeled	2	is	from	the	fullscan	of	the	sample.	A	chromatographic	peak	appears	in	the	SIR	scan	at	8.55	minutes,	labeled	A.	While	there	is	no	corresponding	peak	in	the	fullscan	chromatogram,	the	same	region	has	been	labeled	A.	The	average	mass	spectra	of	these	chromatographic	peaks	are	shown	in	Figure	3.13.	The	mass	spectrum	labeled	1	corresponds	to	that	taken	from	the	peak	at	8.55	minutes	in	the	SIR	chromatogram.	The	mass	spectrum	labeled	2	corresponds	to	approximately	the	same	time	region,	but	taken	from	the	fullscan	chromatogram.	While	SIR	scans	allow	for	increased	sensitivity	in	regard	to	certain	ions,	they	do	not	offer	the	same	comprehensive	identification	of	PLs	as	full	scans,	which	also	include	identifying	cone	fragments.	The	mass	spectrum	taken	from	the	SIR	scan	shows	one	major	peak	at	766.5	m/z	and	a	few	smaller	peaks	at	the	other	masses	that	were	scanned	for,	but	includes	little	other	information.	By	comparison,	the	mass	spectrum	taken	from	the	fullscan	contains	an	abundance	of	fragments.	The	peak	at	766.5	m/z	corresponds	to	the	[M-H]-	of	PE	18:1/20:3,	which	was	confirmed	by	searching	the	LIPID	MAPS	database.	Additionally,	
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cone	fragments	can	be	found	at	281.2	m/z	and	305.2	m/z,	which	correspond	to	18:1	and	20:3.	The	chromatogram	also	includes	many	fragments	that	are	unrelated	to	PE	18:1/20:3.	For	instance,	the	peak	at	740.5	m/z	corresponds	to	the	[M-H]-	of	PE	16:0/20:3,	confirmed	by	the	LIPID	MAPS	database.	This	also	explains	the	presence	of	a	peak	at	255.2	m/z,	which	corresponds	to	16:0.	Additionally,	the	peak	at	434.2	m/z	corresponds	to	the	neutral	loss	of	the	sn-2	group	(20:3)	from	PE	16:0/20:3.	The	peak	at	8.42	minutes	in	the	fullscan	chromatogram	was	identified	as	PE	16:0/20:3,	and	the	presence	of	related	m/z	values	in	the	mass	spectrum	at	8.55	minutes	can	be	explained	by	slight	sampling	off	the	right	hand	tail	of	the	peak	at	8.42	minutes.			
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Figure	3.12.	The	chromatogram	labeled	1	shows	the	SIR	scan	of	the	A.	salmonicida	sample	grown	in	the	presence	of	dihomo-γ-
linolenic	acid	(20:3),	which	selectively	scanned	for	masses	corresponding	to	potentially	modified	PLs.	The	chromatogram	labeled	2	
is	the	phospholipid	region	of	the	fullscan	chromatogram	of	the	same	sample.	The	peak	chosen	for	analysis	is	labeled	A	on	both	
chromatograms.
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Figure	3.13.	The	mass	spectrum	labeled	1	is	the	average	mass	spectrum	of	the	peak	labeled	A	scanned	under	SIR	conditions.	The	
mass	spectrum	labeled	2	is	the	average	mass	spectrum	of	the	peak	labeled	A	scanned	under	fullscan	parameters.
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Figure	3.14	shows	two	chromatograms	of	the	sample	of	A.	salmonicida	grown	in	the	presence	of	arachidonic	acid	(20:4).	The	chromatogram	labeled	1	is	a	SIR	scan	of	the	sample,	and	the	chromatogram	labeled	2	is	from	a	full	scan	of	the	same	sample.	The	same	chromatographic	peak	at	7.03	minutes	is	labeled	A	in	both	chromatograms.	Figure	3.15	shows	the	average	mass	spectra	corresponding	to	the	chromatographic	peak	A	for	both	the	SIR	scan	and	full	scan.	The	mass	spectrum	labeled	1	was	taken	from	the	SIR	scan	and	the	mass	spectrum	labeled	2	was	taken	from	the	full	scan.	Further	analysis	will	only	refer	to	mass	spectrum	2.	The	peak	found	at	795.5	m/z	corresponds	to	the	[M-H]-	value	of	PG	18:1/20:4,	as	confirmed	by	the	LIPID	MAPS	database.	Additionally,	a	cone	fragment	corresponding	to	20:4	can	be	found	at	303.2	m/z.	While	not	visible	in	the	mass	spectrum	in	Figure	3.14,	a	small	peak	at	281.2	m/z	was	found	by	use	of	the	MassLynx	software,	corresponding	to	a	cone	fragment	of	18:1.
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Figure	3.14.	Two	chromatograms	of	the	A.	salmonicida	sample	grown	in	the	presence	of	arachidonic	acid	(20:4).	The	
chromatogram	labeled	1	comes	from	an	SIR	scan	conducted	that	exclusively	scanned	m/z	values	that	correspond	to	possible	
modified	PLs.	The	chromatogram	labeled	2	is	the	PL	region	examined	under	fullscan	parameters.	The	mass	spectra	of	the	peaks	
labeled	A	are	shown	in	Figure	3.14	 	
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Figure	3.15.	The	average	mass	spectra	of	the	peaks	at	approximately	7.03	minutes	from	the	20:3	sample.	The	mass	spectrum	
labeled	1	corresponds	to	that	taken	from	the	SIR	scan,	and	the	mass	spectrum	labeled	2	corresponds	to	that	taken	from	the	scan	
conducted	with	fullscan	parameters.
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Figure	3.16	shows	the	phospholipid	region	of	the	chromatogram	of	the	A.	salmonicida	sample	grown	in	the	presence	of	eicosapentaenoic	acid	(20:5).	The	average	mass	spectrum	of	the	chromatographic	peak	at	7.00	minutes,	labeled	A,	is	shown	in	Figure	3.17.	The	mass	spectrum	peak	at	708.5	m/z	corresponds	to	the	[M-H]-	of	PE	14:0/20:5,	which	was	confirmed	by	referencing	the	LIPID	MAPS	database.	Further	confirmation	of	this	identity	can	be	established	by	the	cone	fragments	at	227.2	m/z	and	301.2	m/z,	which	correspond	to	14:0	and	20:5,	respectively.	The	mass	spectrum	in	Figure	3.17	shows	several	additional	peaks	that	do	not	correspond	to	any	fragmentation	of	PE	14:0/20:5.	Specifically,	the	peak	at	733.5	m/z	could	correspond	to	the	[M-H]-	of	PG	16:0/cyclo17:0	(cy17:0),	as	confirmed	by	the	LIPID	MAPS	database.	This	would	also	explain	the	presence	of	a	cone	fragment	at	255.2	m/z,	which	corresponds	to	16:0.	Additionally,	the	peak	at	465.2	m/z	corresponds	to	the	neutral	loss	of	of	the	sn-2	acyl	chain	(cy17:0)	as	a	ketene,	specifically	corresponding	to	the	m/z	value	of	[M-H-R2-CH=C=O]-.	Although	not	labeled	in	the	mass	spectrum	in	Figure	3.17,	a	cone	fragment	of	267.2	m/z	was	found,	corresponding	to	cy17:0.	This	demonstrates	the	slight	overlap	in	elution	of	PGs	and	PEs	that	occurs	at	around	seven	minutes.
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Figure	3.16.	Chromatogram	of	the	A.	salmonicida	sample	grown	in	the	presence	of	eicosapentaenoic	acid	(20:5),	only	the	
phospholipid	region	is	shown.	The	peak	labeled	A	is	at	7.00	minutes.
A	
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Figure	3.17.	Average	mass	spectrum	of	the	chromatographic	peak	labeled	A	in	Figure	3.15	(7.00	minutes)		
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Figure	3.18	shows	the	phospholipid	region	of	the	chromatogram	from	the	full	scan	run	on	the	A.	salmonicida	sample	grown	in	the	presence	of	300-μM	of	docosahexaenoic	acid	(22:6).	The	chromatographic	peak	of	interest	at	8.12	minutes	is	labeled	A,	and	the	average	mass	spectrum	of	this	peak	is	shown	in	Figure	3.19.	The	peak	in	the	mass	spectrum	at	762.5	m/z	corresponds	to	the	[M-H]-	ion	of	PE	16:0/22:6,	confirmed	by	consulting	the	LIPID	MAPS	database.	Further	confirmation	of	this	identity	can	be	established	by	the	presence	of	cone	fragments	at	255.2	m/z	and	327.2	m/z,	which	correspond	to	16:0	and	22:6,	respectively.	Additionally,	the	peak	at	714.5	m/z	corresponds	to	the	[M-H]-	ion	of	PE	16:1/18:1,	confirmed	via	the	LIPID	MAPS	database.	This	explains	the	presence	of	a	peak	at	253.2	m/z,	which	corresponds	to	16:1.	Additionally,	a	small	peak	at	281.2	m/z	was	observed	in	the	MassLynx	software,	which	corresponds	to	18:1,	further	confirming	the	identity	of	714.5	m/z	as	PE	16:1/18:1.
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Figure	3.18	Chromatogram	of	the	A.	salmonicida	sample	grown	in	the	presence	of	docosahexaenoic	acid	(22:6),	only	the	
phospholipid	region	is	shown.	The	average	mass	spectrum	of	the	chromatographic	peak	at	8.12	minutes	(labeled	A)	is	shown	in	
Figure	3.18.
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Figure	3.19	The	average	mass	spectrum	corresponding	to	the	chromatographic	peak	labeled	A	from	the	A.	salmonicida	sample	
grown	in	the	presence	of	22:6
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3.4	UPLC-MS	Analysis	of	Fatty	Acids	The	linoleic	acid	(18:2)	and	docosahexaenoic	acid	(22:6)	utilized	to	supplement	samples	of	
A.	salmonicida	were	analyzed	by	UPLC-MS	according	to	the	procedure	detailed	in	Section	2.4.4	to	create	calibration	curves	correlating	chromatographic	peak	area	to	concentration	of	free	fatty	acid.	QuanLynx	software	was	utilized	to	determine	peak	areas	and	create	a	linear	regression	of	the	data.	Figure	3.20	shows	the	calibration	curve	of	18:2.	
Figure	3.20	Calibration	curve	of	18:2	correlating	chromatographic	peak	area	to	
concentration.	The	R2	value	is	0.998.		To	avoid	redundancy,	the	calibration	curve	of	22:6	is	omitted,	but	the	linear	regression	and	correlation	value	are	given	in	Equation	1.		 y	=	4.72x105(x)	–	1.68x105,	R2	=	0.991	 	 	 	 	 Equation	(1)	Both	calibration	curves	have	R2	values	greater	than	0.99,	indicating	a	strong	linear	relationship	between	concentration	and	chromatographic	peak	area	for	both	fatty	acids.
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3.5	Growth	Curves	Growth	curves	of	A.	salmonicida	in	either	the	presence	or	absence	of	300	μM	of	one	of	the	seven	PUFAs	were	determined	at	both	28°C	and	23°C.	The	growth	procedure	is	outlined	in	more	detail	in	Section	2.5.	The	growth	curve	conducted	at	28°C	is	shown	in	Figure	3.21,	and	the	growth	curve	conducted	at	23°C	is	shown	in	Figure	3.22.	The	presence	of	300	μM	of	one	of	the	seven	PUFAs	did	not	cause	any	significant	increase	or	decrease	in	growth	rate	compared	to	the	control	sample	grown	without	PUFA	supplementation.		However,	temperature	did	affect	growth	rates	as	the	samples	grown	at	28°C	were	found	to	grow	more	quickly	than	the	samples	grown	at	23°C.	For	this	reason,	growth	of	A.	salmonicida	for	subsequent	assays	was	conducted	at	28°C.	
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Figure	3.21	Growth	curve	of	A.	salmonicida	conducted	at	28°C	
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Figure	3.22	Growth	curve	of	A.	salmonicida	conducted	at	23°C														
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3.6	Biofilm	Results	Biofilm	formation	of	A.	salmonicida	either	in	the	presence	or	absence	of	300-μM	of	one	of	the	seven	PUFAs	was	tested	by	a	method	outlined	by	O’Toole	and	described	in	Section	2.6.28	Biofilms	form	when	communities	of	microbes	attach	to	surfaces	and	are	distinctive	in	their	resistance	to	antimicrobials.28,	30	Biofilms	were	stained	with	CV	and	analyzed	via	UV-Vis	at	590-nm.	Figure	3.23	shows	the	results	of	biofilm	formation.	Student’s	t-test	(two	tailed,	paired)	was	used	to	determine	significant	(P	<	0.01)	differences	in	biofilm	formation	from	the	control	sample	(grown	without	PUFA	supplementation).	It	was	found	that	the	sample	grown	in	the	presence	of	18:2	and	the	sample	grown	in	the	presence	of	22:6	produced	significantly	lower	amounts	of	biofilm	than	the	control	sample.	
Figure	3.23	Biofilm	formation	of	A.	salmonicida,	standard	deviations	are	represented	by	error	
bars,	and	asterisks	indicate	samples	that	varied	significantly	(P	<	0.01)	compared	to	the	
control	sample
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3.7	Permeability	Results	Membrane	permeability	of	A.	salmonicida	was	tested	by	measuring	the	uptake	of	the	hydrophobic	compound	CV	as	described	in	Section	2.7.	Figure	3.24	shows	the	results	of	this	assay,	with	samples	that	varied	significantly	from	the	control	sample	(grown	without	supplementation	of	PUFAs)	marked	by	an	asterisk	(*).	Significance	(P	<	0.001)	was	established	by	Student’s	t-test	(two	tailed,	paired).	It	was	found	that	samples	grown	in	the	presence	of	18:3γ,	20:4,	and	22:6	exhibited	significantly	more	uptake	of	CV	than	the	control	sample.	
Figure	3.24	Results	of	permeability	assay	via	CV	uptake,	samples	that	varied	significantly	(P	<	
0.001)	from	the	the	control	sample	are	marked	with	an	asterisk	(*)
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3.8	Polymyxin	B	Susceptibility	Results	Susceptibility	of	A.	salmonicida	samples	to	an	antimicrobial	peptide	(AMP)	was	tested	by	exposure	to	Polymyxin	B	(PMB)	at	two-fold	increasing	concentrations	according	to	the	procedure	described	in	Section	2.8.		Figure	3.25	shows	the	results	of	PMB	susceptibility	testing.	Samples	that	varied	significantly	from	the	control	sample	are	circled	with	a	dashed	line.	Significance	(P	<	0.001)	was	established	by	Student’s	t-test	(two-tailed,	paired).	The	samples	grown	in	the	presence	of	20:5	and	22:6	showed	twofold	protection,	and	the	sample	grown	in	the	presence	of	18:3γ	showed	fourfold	protection	against	PMB	compared	to	the	control.		
Figure	3.25	Results	of	Polymyxin	B	susceptibility	assay,	samples	that	varied	significantly	(P	<	
0.001)	from	the	control	are	circled	with	a	dashed	line		
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3.9	Bioinformatics	Results	The	results	of	utilizing	the	BLAST	tool	to	compare	known	FadD,	FadL,	PlsB,	PlsC,	ad	PlsX	genes	of	E.	coli	(MG1655)	are	shown	in	table	3.1.	All	homologs	listed	had	a	score	of	greater	than	200.	All	homologs	correspond	to	A.	salmonicida	subsp.	salmonicida	(A449).	
Table	3.1.	Homolog	results	for	A.	salmonicida	subsp.	salmonicida	(A449)		FadD	 FadL	 PlsB,	PlsC,	PlsX	ABO90161,	ABO91337	 ABO90221,	ABO90222	 ABO92136,	ABO88712,	ABO90124,	ABO88617	
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Chapter	4:	Discussion	
4.1	Discussion	
A.	salmonicida	is	a	Gram-negative	fish	pathogen	that	can	have	devastating	effects	on	cultivated	fish	populations.22,	23,	26,	31	Currently,	several	methods	are	employed	to	keep	infections	of	A.	salmonicida	at	a	minimum,	including	the	use	of	a	vaccine,	selective	breeding,	and	the	use	of	antibiotics	in	case	infections	do	arise.22,	32,	33	However,	vaccination	is	a	limited	method	and	has	been	shown	to	have	some	adverse	effects.34	Additionally,	the	efficacy	of	vaccination	of	non-salmonids	has	yet	to	be	explored,	and	A.	salmonicida	often	displays	antibiotic	resistance.26,	35	Thus,	the	need	for	novel	treatments	of	A.	salmonicida	infections	still	exists.	Previous	research	conducted	on	Gram-negative	bacteria	has	shown	certain	species	capable	of	incorporating	polyunsaturated	fatty	acids	(PUFAs)	into	their	lipodomes,	specifically	as	acyl	chains	in	membrane	phospholipids	(PLs).	These	studies	also	found	subsequent	altering	of	biological	functions,	such	as	motility,	permeability,	biofilm	formation,	and	antimicrobial	susceptibility.9-12	The	purpose	of	this	project	was	to	explore	the	ability	of	A.	salmonicida	to	incorporate	PUFAs	into	membrane	PLs	and	determine	any	biological	effects	thereof,	potentially	in	the	light	of	future	therapeutic	efforts	against	furunculosis	infections.	The	first	part	of	this	project	consisted	of	confirming	that	A.	salmonicida	was	capable	of	assimilating	PUFAs	into	its	PL	profile.	This	was	done	by	analyzing	lipids	extracted	from	
A.	salmonicida	cultures	grown	at	23°C	either	in	the	presence	of	one	of	the	seven	PUFAs	of	interest	at	a	concentration	of	300-μM	or	without	PUFA	supplementation.	The	PUFAs	used	in	this	study	were	linoleic	acid	(18:20),	α-linolenic	acid	(18:3α),	γ-linolenic	acid	(18:3γ),	dihomo-γ-linolenic	acid	(20:3),	arachidonic	acid	(20:4),	eicosapentaenoic	acid	(20:5),	and	
	 60	
docosahexaenoic	acid	(22:6).	One	set	of	lipid	extracts	was	analyzed	by	thin-layer	chromatography	(TLC),	the	results	of	which	are	shown	in	section	3.2.	The	presence	of	splitting	can	be	seen	in	samples	grown	in	the	presence	of	one	of	the	PUFAs	that	is	not	present	in	the	control	sample,	indicating	that	the	PL	profile	has	been	altered,	likely	by	incorporation	of	PUFAs.	While	TLC	offered	proof	of	concept,	ultra	performance	liquid	chromatography	and	tandem	mass	spectrometry	(UPLC-MS)	was	utilized	for	more	thorough	analysis	of	the	PL	profile	of	A.	salmonicida	samples,	though	it	was	still	only	used	as	a	qualitative	measure	rather	than	quantitative.	Gradient	elution	on	a	BEH	C-8	column,	explained	in	section	2.4.2,	allowed	for	chromatographic	separation	of	lipid	species,	resulting	in	distinctive	free	fatty	acid	and	PL	regions.	Additionally,	chromatography	resulted	in	almost,	though	not	entirely,	distinct	phosphatidylglycerol	(PG)	and	phosphatidylethanolamine	(PE)	regions.	This	is	to	be	expected	as	certain	combinations	of	headgroup	and	acyl	chain	compositions	can	result	in	identical	(or	nearly	so)	polarities	which	can	be	observed	as	chromatographic	co-elution.	For	example,	even	though	PG	has	a	more	polar	headgroup	than	PE,	if	the	acyl	chains	attached	to	PG	are	extremely	hydrophobic	(e.g.	long-chain,	fully	saturated),	the	polarities	of	that	species,	and	therefore	the	retention	time,	could	be	the	same	as	that	of	a	PE	species	containing	less	hydrophobic	acyl	chains	(e.g.	shorter-chain,	unsaturated).	PL	identities	were	elucidated	by	mass	spectrometry	analysis	conducted	in	negative	electrospray	ionization	mode	(ESI	(-)).	By	scanning	in	ESI	(-),	fragmented	acyl	chains	from	PLs,	which	cleaved	as	a	result	of	the	cone	voltage	(50-V)	as	carboxylate	ions,	were	able	to	be	detected	and	assist	in	identification	of	PLs.	Section	3.3	shows	the	identification	process	of	PLs	by	mass	spectrometry	analysis,	which	was	assisted	by	the	use	of	the	LIPID	MAPS	
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database.	A.	salmonicida	was	shown	to	be	capable	of	incorporating	all	seven	PUFAs	into	its	lipid	profile.	Phospholipids	were	identified	by	their	(PX	sn-1/sn-2)	notation,	where	PX	is	the	identity	of	the	headgroup,	and	sn-1	and	sn-2	are	the	identities	of	the	acyl	chains	(carbons:	number	of	double	bonds)	at	the	sn-1	and	sn-2	positions.	It	should	be	noted	that	acyl	chains	on	the	sn-1	position	are	usually	saturated	or	monounsaturated,	compared	to	the	sn-2	position,	which	has	an	established	preference	for	unsaturated	chains.36	Additionally,	studies	conducted	on	the	analysis	of	PGs	and	PEs	have	found	preferential	loss	of	the	sn-2	acyl	chain	in	triple	quadrupole	mass	spectrometry	analysis	also	conducted	in	ESI	(-)	mode.16,	17	This	results	in	a	higher	signal	of	the	cone	fragment	corresponding	to	the	sn-2	chain	than	that	of	the	sn-1	chain,	though	this	is	not	always	observed.	The	fact	that	the	sn-2	position	preferentially	takes	saturated	fatty	acids	coupled	with	the	observed	intensities	of	the	cone	fragments	influenced	the	order	in	which	the	acyl	chains	were	reported	in	the	PLs	identified	in	Section	3.3.	One	potential	interference	with	the	use	of	cone	fragment	intensity	in	specifying	the	identity	of	the	sn-1	and	sn-2	positions	is	the	sensitivity	of	the	fatty	acids.	The	linoleic	acid	(18:2)	and	docosahexaenoic	acid	(22:6)	utilized	to	supplement	samples	of	A.	salmonicida	were	analyzed	by	UPLC-MS	and	used	to	create	calibration	curves	ranging	in	concentration	from	0.5-	to	5-ppm.	Both	fatty	acids	yielded	strong	correlation	values	(R2	>	0.99),	but	18:2	showed	greater	than	ten	times	more	sensitivity	than	22:6,	as	seen	by	the	values	of	the	slopes	(m)	of	the	calibration	curves	(m18:2	=	5.04x106,	m22:6	=	4.72x105).	This	is	likely	due	to	increased	fragmentation	of	the	more	highly	unsaturated	fatty	acids.21	This	also	explains	the	lower	peaks	corresponding	to	free	fatty	acids	of	more	highly	unsaturated	PUFAs	as	
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compared	to	more	saturated	PUFAs,	as	signal	of	the	[M-H]-	ion	is	lost	to	fragmentation.	Chromatograms	and	mass	spectra	demonstrating	this	fragmentation	and	lower	signal	can	be	found	in	supplemental	material	S1.	
	 Selected	ion	recording	(SIR)	scans	were	also	performed	on	lipid	extractions	of	all	A.	
salmonicida	samples	that	were	grown	in	the	presence	of	one	of	the	seven	PUFAs.	This	mass	spectrometry	technique	selectively	scans	for	specified	m/z	values.	For	each	of	the	seven	samples,	SIR	scans	were	designed	with	ten	m/z	values,	which	are	given	in	Table	2.1.	Eight	of	those	values	corresponded	to	the	m/z	values	of	the	[M-H]-	ions	of	the	most	probable	substituted	PLs,	and	the	other	two	m/z	values	corresponded	to	the	[M-H]-	ions	of	a	doubly	substituted	PG	and	PE.	SIR	scans	allow	for	increased	sensitivity,	which	can	be	particularly	useful	as	modified	PLs	are	lower	abundance	than	naturally	occurring	PLs.	However,	SIR	scans	do	not	allow	for	the	same	positive	identification	of	PLs	as	full	scan	analysis	does,	because	cone	fragments	are	not	scanned	for.	Additionally,	certain	m/z	values	can	correspond	to	other	PLs	that	are	not	of	interest.	For	example,	714.5	m/z	corresponds	to	the	[M-H]-	of	PE	16:0/18:2,	but	it	also	corresponds	to	the	[M-H]-	of	PE	16:1/18:1,	which	could	occur	natively.	Another	such	example	is	that	743.5	m/z	corresponds	to	PG	16:0/18:3	(for	both	18:3α	and	18:3γ),	but	it	also	corresponds	to	the	[M+1-H]-	of	PE	18:1/18:1,	which	could	occur	natively.	Thus,	SIR	scans	cannot	be	used	by	themselves	to	identify	phospholipids,	but	they	can	be	useful	in	identifying	chromatographic	peaks	of	modified	phospholipids	that	may	have	otherwise	been	lost	to	noise	under	full	scan	parameters.	As	shown	in	the	analysis	conducted	in	section	3.3,	once	chromatographic	peaks	of	interest	have	been	identified	with	SIR	scans,	the	mass	spectrum	corresponding	to	the	same	
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chromatographic	region	of	the	equivalent	full	scan	run	can	be	analyzed	for	fragmentation	that	confirms	the	identity	of	the	lipid	of	interest.		 After	confirmation	of	PUFA	incorporation	via	TLC	and	UPLC-MS	analysis	was	established,	a	series	of	assays	were	conducted	to	test	the	effect	of	PUFAs	on	growth,	biofilm	formation,	permeability,	and	susceptibility	to	polymyxin	B	(PMB).	Growth	curves	of	A.	
salmonicida	were	conducted	at	23°C	and	28°C	according	to	the	procedure	detailed	in	Section	2.5.	Optimal	growth	temperatures	for	A.	salmonicida	are	reported	to	be	between	18°C	and	26°C,	with	little	growth	at	temperatures	as	low	as	4°C	and	typically	no	growth	seen	at	37°C.22,	24	The	presence	of	PUFAs	did	not	have	any	significant	effect	on	growth	of	A.	
salmonicida	at	either	temperature.	It	was	found	that	A.	salmonicida	samples	grown	at	28°C	grew	at	a	quicker	rate	than	those	grown	at	23°C	up	until	the	eighth	hour	of	growth,	when	both	sets	approach	the	stationary	phase	of	growth.	This	was	unexpected,	considering	28°C	is	above	reported	optimal	temperatures	for	A.	salmonicida	growth.	Because	A.	salmonicida	grew	more	quickly	at	28°C,	this	temperature	was	used	for	growth	in	all	subsequent	assays.		 The	formation	of	biofilm	was	tested	by	a	method	designed	by	O’Toole	and	outlined	in	Section	2.6.28	Biofilms	are	communities	of	microorganisms	that	are	attached	to	a	surface,	such	that	they	cannot	be	removed	by	gentle	rinsing.30	Biofilms	are	often	notable	for	their	antimicrobial	resistance	as	compared	to	planktonic	microbes.30,	37	The	biofilm	assay	conducted	on	A.	salmonicida	in	either	the	presence	of	one	of	the	seven	PUFAs	or	without	PUFA	supplementation	showed	significantly	(P	<	0.01)	lower	production	of	biofilm	by	the	cultures	supplemented	with	18:2	and	22:6	compared	to	the	control	culture.	However,	some	of	the	standard	deviations	were	quite	large,	such	as	22.6%	for	the	18:3γ	sample	and	21.6%	for	the	20:3	sample.	It	was	shown	that	biofilm	formation	can	be	affected	significantly	by	
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PUFAs	as	with	the	18:2	and	22:6	samples,	but	further	testing	should	be	conducted	before	settling	on	conclusive	results	of	biofilm	testing	due	to	the	high	deviations	seen	in	some	samples.		 Membrane	permeability	was	tested	by	measuring	uptake	of	the	hydrophobic	compound	crystal	violet	(CV)	by	the	procedure	described	in	Section	2.7.	Membrane	permeability	can	have	a	major	impact	on	bacteria,	as	it	determines	the	passage	of	molecules	between	the	cell	and	its	environment.	Membrane	permeability	has	been	linked	to	functions	such	as	antibiotic	resistance.38	The	results	of	permeability	testing	showed	that	the	A.	salmonicida	samples	grown	in	the	presence	of	18:3γ,	20:4	and	22:6	showed	significantly	(P<0.001)	greater	permeability	than	the	control	sample.	The	increase	in	double	bonds	and	specifically	the	cis-configuration	of	the	bonds	could	contribute	to	the	increased	permeability,	though	this	does	not	explain	why	only	those	three	PUFAs	affected	permeability	significantly.		 Antibiotic	resistance	is	a	major	concern	in	regard	to	A.	salmonicida.22,	23,	35,	37	Antimicrobial	peptides	(AMPs)	are	a	class	of	antibiotics	that	specifically	target	the	bacterial	membrane	and	are	promising	in	that	the	use	of	AMPs	is	less	likely	to	lead	to	resistance	than	traditional	antimrobials.39	Because	AMPs	target	the	bacterial	membrane,	membrane	modification	caused	by	the	incorporation	of	exogenous	PUFAs	could	affect	the	efficacy	of	AMPs.	The	susceptibility	of	A.	salmonicida	samples	grown	in	the	presence	of	one	of	the	seven	PUFAs	or	without	PUFA	supplementation	to	the	AMP	Polymyxin	B	(PMB)	was	tested	according	to	the	procedure	outlined	in	Section	2.8.	It	was	found	that	cultures	grown	in	the	presence	of	20:5	and	22:6	had	two-fold	minimum	inhibitory	concentration	(MIC)	protection	against	PMB	as	compared	to	the	control	sample	(P<0.001).	Additionally,	
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cultures	grown	in	the	presence	of	18:3γ	showed	fourfold	MIC	protection	against	PMB	compared	to	the	control	sample	(P<0.001).	None	of	the	PUFAs	studied	increased	the	susceptibility	of	A.	salmonicida	to	PMB.	The	increased	permeability	caused	by	18:3γ,	20:4,	and	22:6	would	cause	one	to	expect	increased	susceptibility	to	an	AMP	as	it	specifically	targets	the	bacterial	membrane.	PMB	specifically	functions	by	altering	membrane	permeability	by	binding	to	a	negatively	charged	site	in	the	lipopolysaccharide	layer.40	However,	because	of	the	structure	of	Gram-negative	membranes,	PMB	must	permeabilize	both	the	outer	and	inner	membranes,	and	the	barrier	posed	by	the	inner	membrane	often	takes	longer	to	permeabilize.39	It	is	possible	that	the	modification	allowed	for	increased	permeability	of	hydrophobic	compounds	such	as	CV,	while	providing	some	form	of	protection	against	AMPs	due	to	mechanistic	differences	by	which	the	molecules	permeate	the	membrane.	The	incorporation	of	exogenous	PUFAs	into	membrane	lipids	in	the	model	organism	
E.	coli	has	been	connected	to	an	outer	membrane	transporter	of	long-chain	fatty	acids	(FadL),	an	acyl-CoA	synthetase	(FadD),	and	acyltransferases	(PlsB,	PlsC,	PlsX,	and	PlsY).9,	13,	
14,	41	Previous	research	has	found	that	the	presence	of	homologs	of	these	genes	in	other	species	can	indicate	their	capacity	for	membrane	modification.9,	10	The	use	of	the	National	Center	of	Biotechnology	Information’s	Basic	Local	Alignment	Search	Tool	(BLAST)	revealed	that	A.	salmonicida	subsp.	salmonicida	(A449)	has	two	FadL	homologs,	two	FadL	homologs,	and	four	homologs	corresponding	to	PlsB,	PlsC,	PlsX,	and	PlsY.	These	homologs	are	given	in	Table	3.1.	The	identification	of	these	homologs	further	confirms	that	A.	salmonicida	should	be	capable	of	membrane	modification	by	exogenous	PUFA	incorporation,	which	has	been	shown	by	this	research.	
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Interestingly,	A.	salmonicida	samples	grown	in	the	presence	of	22:6	showed	significant	deviations	from	the	control	sample	in	biofilm	formation,	permeability,	and	antimicrobial	resistance.	Docosahexaenoic	acid	is	an	ω-3	fatty	acid	that	is	extremely	prevalent	in	fish.42	Because	A.	salmonicida	is	a	fish	pathogen,	it	is	possible	that	it	has	developed	a	specific	affinity	for	22:6.	
4.2	Future	work		 Future	work	to	be	conducted	on	A.	salmonicida	includes	revisiting	the	effects	of	PUFAs	on	biofilm	formation	to	be	able	to	draw	stronger	conclusions.	Additionally,	the	effect	of	temperature	on	growth	could	continue	to	be	explored	to	see	at	what	temperature	the	growth	rate	of	A.	salmonicida	declines.	Additionally,	the	fatty	acid	calibration	curves	created	could	be	used	in	first	attempts	at	quantitative	analysis	of	modified	lipids	by	quantifying	the	amount	of	free	fatty	acid	that	elutes	in	a	sample	and	referencing	the	original	300-μM	concentration	of	the	fatty	acid	during	growth	to	determine	how	much	was	used	for	incorporation	by	difference.	Future	projects	could	also	see	if	similar	Gram-negative	aquatic	pathogens	experience	as	much	phenotypic	alteration	following	incorporation	of	22:6	as	A.	salmonicida.		
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Supplemental	Material	
Table	S.1	Masses	of	A.	salmonicida	Dried	Lipid	Extracts	
Sample 
Mass of empty LC 
vial (g) 
Mass of LC Vial 
with Dried Lipid 
Extract (g) 
Average Mass of Dried 
Lipid Extract (mg) 
A. salmonicida (-) 
2.55094 2.55151 
0.56 
2.55094 2.55150 
2.55091 2.55145 
A. salmonicida 18:2 
2.59898 2.60002 
1.08 
2.59893 2.60001 
2.59892 2.60003 
A. salmonicida 18:3α 
2.51958 2.52026 
0.66 
2.51956 2.52022 
2.51955 2.52018 
A. salmonicida 18:3γ 
2.55526 2.55616 
0.90 
2.55524 2.55616 
2.55525 2.55614 
A. salmonicida 20:3 
2.60128 2.60291 
1.65 
2.60128 2.60293 
2.60124 2.60290 
A. salmonicida 20:4 
2.52411 2.52486 
0.75 
2.52411 2.52486 
2.52410 2.52484 
A. salmonicida 20:5 
2.59008 2.59112 
1.04 
2.59007 2.59109 
2.59005 2.59112 
A. salmonicida 22:6 
2.55992 2.56045 
0.52 
2.55989 2.56044 
2.55992 2.56041 
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Figure	S.1	Chromatogram	of	5	ppm	18:2	sample,	peak	at	1.87	minutes	corresponds	to	elution	of	the	fatty	acid	
	
Figure	S.2	Chromatogram	of	5	ppm	22:6	sample,	peak	at	1.81	minutes	corresponds	to	elution	of	the	fatty	acid							
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Figure	S.3	Overlaid	chromatograms	of	5	ppm	18:2	(red)	and	5	ppm	22:6	(green),	vertical	axis	is	linked	to	show	the	greater	intensity	of	the	18:2	peak,	even	though	both	samples	were	sized	to	5	ppm.		
	
	
Figure	S.4	Average	mass	spectrum	of	the	chromatographic	peak	at	1.87	minutes	of	the	5	ppm	18:2	sample.	Peak	at	279.2	m/z	corresponds	to	[M-H]-	carboxylate	ion	of	18:2	and	peak	at	280.2	m/z	corresponds	to	the	M+1	isotope	of	18:2	carboxylate	ion.						
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Figure	S.5	Average	mass	spectrum	of	the	chromatographic	peak	at	1.81	minutes	of	the	5	ppm	sample	of	22:6.	The	peak	at	327.2	m/z	corresponds	to	the	carboxylate	ion	of	22:6.	The	peak	at	283.2	m/z	corresponds	to	the	[M-H-C=O-O]-	fragment	of	22:6.	The	overall	increase	in	fragmentation	compared	to	18:2	could	explain	the	lower	intensity	of	the	22:6	sample.	
